Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinoma

Urology

Volumn 65, Issue 4, 2005, Pages 815-820

  Seargent, Jill M ^b   Loadman, Paul M ^b   Martin, Sandie W ^b   Naylor, Brian ^b   Bibby, Michael C ^b   Gill, Jason H ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STROMELYSIN 2;

ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LOCALIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH;

EID: 17144374466     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.11.016     Document Type: Article

References (32)

1. M. Egeblad, Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 2002 161 174
2. M.J. Duffy, K. McCarthy Matrix metalloproteinases in cancer prognostic markers and targets for therapy Int J Oncol 12 1998 1343 1348
3. C.M. Overall, C. Lopez-Otin Strategies for MMP inhibition in cancer innovations for the post-trial era Nat Rev Cancer 2 2002 657 672
4. I. Stamenkovic Extracellular matrix remodeling the role of matrix metalloproteinases J Pathol 200 2003 448 464
5. N. Ramos-DeSimone, E. Hahn-Dantona, J. Sipley Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion J Biol Chem 274 1999 13066 13076
6. H. Nakamura, Y. Fujii, E. Ohuchi Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases Eur J Biochem 253 1998 67 75
7. P. Vihinen, V.M. Kahari Matrix metalloproteinases in cancer prognostic markers and therapeutic targets Int J Cancer 99 2002 157 166
8. M.J. Duffy, T.M. Maguire, A. Hill Metalloproteinases role in breast carcinogenesis, invasion and metastasis Breast Cancer Res 2 2000 252 257
9. J. Gill, I. Kirwan, J. Seargent MMP-10 is overexpressed, proteolytically active and a potential target for therapeutic intervention in human lung carcinomas Neoplasia 6 2004 777 785
10. U. Impola, V.J. Uitto, J. Hietanen Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer J Pathol 202 2004 14 22
11. P. O'Charoenrat, P.H. Rhys-Evans, S.A. Eccles Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck Arch Otolaryngol Head Neck Surg 127 2001 813 820
12. R. Mathew, R. Khanna, R. Kumar Stromelysin-2 overexpression in human esophageal squamous cell carcinoma potential clinical implications Cancer Detect Prev 26 2002 222 228
13. E. Kerkela, R. Ala-Aho, J. Lohi Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers Br J Cancer 84 2001 659 669
14. H.D. Foda, S. Zucker Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis Drug Discov Today 6 2001 478 482
15. D. Muller, R. Breathnach, A. Engelmann Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours Int J Cancer 48 1991 550 556
16. Cancer Research UK, CancerStats Report: Bladder Cancer, London, UK, 2002.
17. Cancer Research UK: Cancer statistics. Available at: http://www. cancerresearchuk.org. Accessed June 2004.
18. T. Sumi, H. Yoshida, Y. Hyun Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder Oncol Rep 10 2003 345 349
19. J.E. Nutt, G.C. Durkan, J.K. Mellon Matrix metalloproteinases (MMPs) in bladder cancer the induction of MMP9 by epidermal growth factor and its detection in urine BJU Int 91 2003 99 104
20. P.J. Bostrom, L. Ravanti, N. Reunanen Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder Int J Cancer 88 2000 417 423
21. F.J. Bianco Jr, D.C. Gervasi, R. Tiguert Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade Clin Cancer Res 4 1998 3011 3016
22. F. Monier, A. Surla, M. Guillot Gelatinase isoforms in urine from bladder cancer patients Clin Chim Acta 299 2000 11 23
23. K. Vasala, P. Paakko, T. Turpeenniemi-Hujanen Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer Urology 62 2003 952 957
24. Y. Miyata, S. Kanda, K. Nomata Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract correlation with tumor stage and survival Urology 63 2004 602 608
25. L. Bubendorf, A. Nocito, H. Moch Tissue microarray (TMA) technology miniaturized pathology archives for high-throughput in situ studies J Pathol 195 2001 72 79
26. A. Hoos, C. Cordon-Cardo Tissue microarray profiling of cancer specimens and cell lines opportunities and limitations Lab Invest 81 2001 1331 1338
27. A. Nocito, L. Bubendorf, E. Maria Tinner Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade J Pathol 194 2001 349 357
28. L. Nakopoulou, H. Gakiopoulou, A. Zervas MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer A comparison with clinicopathologic features and survival Appl Immunohistochem Mol Morphol 9 2001 130 137
29. I. Bertini, V. Calderone, M. Fragai Crystal structure of the catalytic domain of human matrix metalloproteinase 10 J Mol Biol 336 2004 707 716
30. O. Rechardt, O. Elomaa, M. Vaalamo Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines J Invest Dermatol 115 2000 778 787
31. W. Hindermann, A. Berndt, K.M. Haas Immunohistochemical demonstration of the gamma2 chain of laminin-5 in urinary bladder urothelial carcinoma. Impact for diagnosis and prognosis Cancer Detect Prev 27 2003 109 115
32. R. Kannan, M. Ruff, J.G. Kochins Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors Protein Expr Purif 16 1999 76 83